1. Home
  2. VAXX

VAXX

Vaxxinity Inc.

Logo Vaxxinity Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 11:14am EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Vaxxinity Inc is engaged in the development and commercialization of prophylactic and therapeutic vaccines to combat chronic disorders and infectious diseases with large patient populations and unmet medical needs. Its pipeline primarily consists of five programs focused on chronic disease, particularly neurodegenerative disorders, in addition to other neurology and cardiovascular indications.

Founded: 2019 Country:
United States
United States
Employees: N/A City: EXPLORATION PARK
Market Cap: 87.3M IPO Year: 2021
Target Price: $7.00 AVG Volume (30 days): 412.8K
Analyst Decision: Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.45 EPS Growth: N/A
52 Week Low/High: $0.52 - $3.10 Next Earning Date: 05-07-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: